MEF2C repressor variant deregulation leads to cell cycle re-entry and development of heart failure
Author(s) -
Ana Helena Macedo Pereira,
Alisson C. Cardoso,
Sílvio Roberto Consonni,
Renata Rocha de Oliveira,
Ângela Saito,
Maria Luisa B. Vaggione,
José R. MatosSouza,
Marcelo Falsarella Carazzolle,
Anderson Gonçalves,
Juliano Lara Fernandes,
Gustavo C. A. Ribeiro,
Maurício Marson Lopes,
Jeffery D. Molkentin,
Kleber G. Franchini
Publication year - 2020
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 63
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2019.11.032
Subject(s) - mef2c , biology , mef2 , microbiology and biotechnology , alternative splicing , downregulation and upregulation , cancer research , transcription factor , genetics , gene , gene isoform , enhancer
São Paulo Research Foundation (FAPESP); Brazilian National Research Council (CNPq).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom